Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

This study has been completed.
Information provided by (Responsible Party):
Avraham Pharmaceuticals Ltd Identifier:
First received: May 1, 2011
Last updated: July 22, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)